Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$31.96 - $46.5 $127,840 - $186,000
-4,000 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$22.8 - $37.05 $91,200 - $148,200
4,000 New
4,000 $133,000

Others Institutions Holding CCCC

About C4 Therapeutics, Inc.


  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $230M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Saltoro Capital, LP Portfolio

Follow Saltoro Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saltoro Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Saltoro Capital, LP with notifications on news.